American Society for Dermatologic Surgery Dermatologic Surgery Drug and Device Nomenclature Recommendations

Background There is a lack of consensus regarding appropriate nomenclature for drugs and devices used in surgical and cosmetic dermatology. Objective To develop a rules‐based system for naming drugs and devices commonly used in dermatologic surgery that generates identifiers and modifiers that are c...

Full description

Saved in:
Bibliographic Details
Published in:Dermatologic surgery 2013-08, Vol.39 (8), p.1158-1166
Main Authors: Alam, Murad, Dover, Jeffrey S.
Format: Article
Language:English
Subjects:
Adipose Tissue - transplantation
Consensus Development Conferences as Topic
Cosmetic Techniques
Dermatologic Agents
Dermatologic Surgical Procedures - classification
Dermatologic Surgical Procedures - instrumentation
Humans
Keratolytic Agents
Rhytidoplasty
Societies, Medical
Terminology as Topic
United States
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background There is a lack of consensus regarding appropriate nomenclature for drugs and devices used in surgical and cosmetic dermatology. Objective To develop a rules‐based system for naming drugs and devices commonly used in dermatologic surgery that generates identifiers and modifiers that are clear, complete, and brief. Methods Using an iterative modified consensus process, five subject‐area work groups of the ASDS Lexicon Task Force were charged with developing standard terminology for the drugs and devices subsumed under their topic. A subcommittee comprising the chairs of the workgroups initially developed the general rules that guided the consensus process; subsequently, this subcommittee merged the 5 resulting documents into a single work product. Two external reviewers with expertise in dermatologic drugs and devices reviewed the final document for errors and omissions. Results General characteristics sought in systematic names included: brevity, clarity, non‐overlapping (mutually exclusive) nature, within‐class similarity, preservation of current usage when possible, and potential for inclusion of future refinements. Conclusion Naming of drugs and devices in dermatologic surgery can be improved to increase comprehensibility and utility in both clinical and research contexts. Particularly for devices, the use of systematic names can reduce repeated mention of proprietary names in scientific discourse. Any naming system should be amenable to modification, correction, and the continual incorporation of novel agents.
ISSN:1076-0512
1524-4725
DOI:10.1111/dsu.12253